InvestorsHub Logo

doogdilinger

07/28/15 10:34 AM

#12406 RE: hogfan2 #12405

Agreed hog...IPCI's Rexista delivery tech platform has a real shot at a best-in-class designation...and casual observers still under-estimating the fact that all of IPCI's ANDA's are in the hard to manufacture category which IPCI's proven to have no struggles with whatsoever compared to 1 of the big 5 biotech's TEVA who struggled for ages trying to even manufacture FocalinXR right!

We've all done extensive due here and know what we own...only a matter of time now 'til the FDA starts releasing the pent up IPCI catalysts en route and we never look back as the +$5 & +$10 institutions initiate their several year long accumulation waves choo-choo;)